Skip to content

Comparison of chloroprocaine and bupivacaine for SUBARACHNOID BLOCK

Comparison of efficacy and safety of 2chloroprocaine 1 percent with hyperbaric bupivacaine 0.5 percent in subarachnoid block for cesarean section - ChlorprocaineCS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031464
Enrollment
96
Registered
2021-02-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O269- Pregnancy related conditions, unspecified

Interventions

Intervention1: Use of heavy bupivacaine and chloroprocaine in Sub arachnoid block: Comparison of heavy bupivacaine and chloroprocaine efficacy and safety in subarachnoid block for Lower segment cesari

Sponsors

Dr SUJEET RAI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant Female patients aged between 18-35 years undergoing elective caesarean section of American society of anaesthesiology (ASA) physical status I and II and giving consent will be included.

Exclusion criteria

Exclusion criteria: Patient refusal or uncooperative patients, Patients with severe cardiopulmonary disease, allergy or intolerance to local anaesthetics, coagulation disorders, neurologic disease or spine deformities, Infection at the site of needle insertion, of ASA physical status 3 and 4 will be excluded.

Design outcomes

Primary

MeasureTime frame
To evaluate and compare the efficacy of Chloroprocaine HCI 1 percent with Hyperbaric Bupivacaine 0.5 percent in spinal anaesthesia for lower segment caesarean section on the basis of duration of analgesia peak height of block time of onset recovery and time of ambulationTimepoint: 1 year

Secondary

MeasureTime frame
To evaluate and compare the efficacy of Chloroprocaine HCI 1 percent with Hyperbaric Bupivacaine 0.5 percent in spinal anaesthesia for lower segment caesarean section on the basis of duration of analgesia peak height of block time of onset recovery and time of ambulationTimepoint: 1 year

Countries

India

Contacts

Public ContactDr sharif

Dr. RMLIMS LUCKNOW

drsujeetrai@gmail.com9161758940

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026